{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:12:31Z","timestamp":1789866751826,"version":"4.0.1"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:00:00Z","timestamp":1464134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"Task Force of the Global Drug-Resistant TB Initiative on Drug-Resistant TB Research"},{"name":"Task Force of the Global Drug-Resistant TB Initiative on Drug-Resistant TB Research"},{"name":"Task Force of the Global Drug-Resistant TB Initiative on Drug-Resistant TB Research"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0155968","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T13:41:10Z","timestamp":1464183670000},"page":"e0155968","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda"],"prefix":"10.1371","volume":"11","author":[{"given":"Carole D.","family":"Mitnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0023-2111","authenticated-orcid":true,"given":"Carly A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita L.","family":"Hatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grania","family":"Brigden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cobelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Grobusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Horsburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lienhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Oren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Podewils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Seaworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"van den Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes C.","family":"Gebhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser","family":"Wares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"key":"ref1","unstructured":"Global tuberculosis report 2015. Geneva: World Health Organization; 2015 (WHO\/HTM\/TB\/2015.22)."},{"key":"ref2","article-title":"Emergency update 2008","year":"2008"},{"key":"ref3","volume":"2011","year":"2011"},{"key":"ref4","year":"2014"},{"key":"ref5","year":"2006"},{"key":"ref6","unstructured":"Global tuberculosis report 2013. Geneva: World Health Organization; 2013 (WHO\/HTM\/TB\/2013.11)"},{"key":"ref7","unstructured":"Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (WHO\/HTM\/TB\/2014.08)."},{"issue":"5","key":"ref8","first-page":"410","article-title":"A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB)","volume":"7","author":"R Gupta","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1371\/journal.pmed.0050150","article-title":"Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda","volume":"5","author":"FG Cobelens","year":"2008","journal-title":"PLoS Med"},{"issue":"Suppl 4","key":"ref10","doi-asserted-by":"crossref","first-page":"S1187","DOI":"10.1093\/infdis\/jir412","article-title":"Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact","volume":"204","author":"RJ Lessells","year":"2011","journal-title":"J Infect Dis"},{"issue":"9760","key":"ref11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(10)61972-1","article-title":"Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study","volume":"377","author":"MC Becerra","journal-title":"Lancet"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"e1001358","DOI":"10.1371\/journal.pmed.1001358","article-title":"Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review","volume":"9","author":"F Cobelens","year":"2012","journal-title":"PLoS Med"},{"issue":"9732","key":"ref13","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0140-6736(10)60554-5","article-title":"Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action","volume":"375","author":"BJ Marais","journal-title":"Lancet"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5588\/ijtld.13.0110","article-title":"Planning for the invisible: projecting resources needed to identify and treat all patients with MDR-TB","volume":"17","author":"CD Mitnick","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref15","article-title":"Prevention, Diagnosis, and Treatment of Tuberculosis in Children and Mothers: Evidence for Action for Maternal, Neonatal, and Child Health Services","author":"H Getahun","year":"2012","journal-title":"J Infect Dis"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1440-1843.2010.01738.x","article-title":"Drug-resistant tuberculosis: Past, present, future","volume":"15","author":"C-Y Chiang","year":"2010","journal-title":"Respirology"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.5588\/ijtld.10.0221","article-title":"Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects","volume":"15","author":"VM Gammino","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1745-6215-14-88","article-title":"Randomized clinical trials to identify optimal antibiotic treatment duration","volume":"14","author":"CR Horsburgh","year":"2013","journal-title":"Trials"},{"issue":"5","key":"ref19","first-page":"528","article-title":"Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities","volume":"14","author":"C Lienhardt","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/INF.0b013e31826f6063","article-title":"Tuberculosis in Children Exposed at Home to Multidrug-resistant Tuberculosis","volume":"32","author":"MC Becerra","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1473-3099(11)70366-8","article-title":"Management of children exposed to multidrug-resistant Mycobacterium tuberculosis","volume":"12","author":"JA Seddon","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5588\/ijtld.11.0437","article-title":"Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews","volume":"16","author":"MJ van der Werf","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S1473-3099(10)70201-2","article-title":"Priorities for tuberculosis research: a systematic review","volume":"10","author":"J Rylance","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-3156.2009.02462.x","article-title":"World TB Day 2010 \u2013New innovations are required for enhancing the global fight against Tuberculosis: the \u2018Captain of all these men of death\u2019","volume":"15","author":"J Grange","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","article-title":"Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis","volume":"182","author":"A Van Deun","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1745-6215-15-353","article-title":"Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial","volume":"15","author":"AJ Nunn","year":"2014","journal-title":"Trials"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.5588\/ijtld.14.0100","article-title":"Successful &apos;9-month Bangladesh regimen&apos; for multidrug-resistant tuberculosis among over 500 consecutive patients","volume":"18","author":"KJ Aung","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJMoa1313865","article-title":"Multidrug-resistant tuberculosis and culture conversion with bedaquiline","volume":"371","author":"AH Diacon","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1183\/09031936.00125812","article-title":"Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis","volume":"41","author":"V Skripconoka","year":"2013","journal-title":"Eur Respir J"},{"key":"ref30","unstructured":"M\u00e9decins Sans Fronti\u00e8res. endTB, Expand New Drug Markets for TB 2014 [November 6, 2015]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.msf.org\/sites\/msf.org\/files\/1503_endtb_presdoc_new.pdf\" xlink:type=\"simple\">http:\/\/www.msf.org\/sites\/msf.org\/files\/1503_endtb_presdoc_new.pdf<\/ext-link>."},{"key":"ref31","unstructured":"Partners in Health. PIH among Groups Bringing New TB Treatment to Those in Need 2015 [November 6, 2015]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.pih.org\/press\/pih-among-organizations-bringing-new-tb-treatment-to-those-in-need\" xlink:type=\"simple\">http:\/\/www.pih.org\/press\/pih-among-organizations-bringing-new-tb-treatment-to-those-in-need<\/ext-link>."},{"issue":"23","key":"ref32","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"TR Sterling","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/cit655","article-title":"Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study","volume":"57","author":"JA Seddon","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/AAC.02755-13","article-title":"Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children","volume":"58","author":"S Thee","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/INF.0000000000000260","article-title":"Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis","volume":"33","author":"FC Adler-Shohet","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009\u20132012","volume":"18","author":"S Bamrah","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/INF.0b013e31829157e9","article-title":"Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom","volume":"32","author":"B Williams","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"ref38","unstructured":"Clayden P, Collins S, Frick M, Harrington M, Horn T, Jefferys R, et al. 2015 Pipeline Report: HIV, hepatitis C visus (HCV), and tuberculosis (TB). Drugs, diagnostics, vaccines, preventive technologies, research towards a cure, and immune-based and gene therapies in development New York, NY: HIV i-Base\/Treatment Action Group; 2015 [November 6, 2015]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/i-base.info\/htb\/28492\" xlink:type=\"simple\">http:\/\/i-base.info\/htb\/28492<\/ext-link>."},{"key":"ref39","unstructured":"Network I. IMPAACT 2003B: (PHOENIx) (DAIDS ID 12041): Protecting Households on Exposure to Newly Diagnosed Index Multidrug-Resistant TB Patients 2015 [cited 2015 December 14]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/impaactnetwork.org\/studies\/IMPAACT2003B.asp\" xlink:type=\"simple\">http:\/\/impaactnetwork.org\/studies\/IMPAACT2003B.asp<\/ext-link>."},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"e65421","DOI":"10.1371\/journal.pone.0065421","article-title":"Time to Treatment and Patient Outcomes among TB Suspects Screened by a Single Point-of-Care Xpert MTB\/RIF at a Primary Care Clinic in Johannesburg, South Africa","volume":"8","author":"CF Hanrahan","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/cid\/cir1039","article-title":"Characteristics and Early Outcomes of Patients With Xpert MTB\/RIF-Negative Pulmonary Tuberculosis Diagnosed During Screening Before Antiretroviral Therapy","volume":"54","author":"SD Lawn","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"ofu038","DOI":"10.1093\/ofid\/ofu038","article-title":"Impact of Xpert MTB\/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial","volume":"1","author":"L Mupfumi","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"e0123252","DOI":"10.1371\/journal.pone.0123252","article-title":"Impact on Patients\u2019 Treatment Outcomes of XpertMTB\/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial","volume":"10","author":"A Trajman","year":"2015","journal-title":"PLoS ONE"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"e48599","DOI":"10.1371\/journal.pone.0048599","article-title":"Impact of Xpert MTB\/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda","volume":"7","author":"C Yoon","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"e1001766","DOI":"10.1371\/journal.pmed.1001766","article-title":"Impact of replacing smear microscopy with Xpert MTB\/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial","volume":"11","author":"B Durovni","year":"2014","journal-title":"PLoS Med"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1183\/09031936.00175812","article-title":"Multidrug-resistant tuberculosis in children: evidence from global surveillance","volume":"42","author":"M Zignol","year":"2013","journal-title":"Eur Respir J"},{"key":"ref47","unstructured":"Frick M. Tuberculosis Research and Development: 2014 Report on Tuberculosis Research Funding Trends, 2005\u20132013. Treatment Action Group Stop TB Partnership, 2014."},{"key":"ref48","unstructured":"M\u00e9decins Sans Fronti\u00e8res. The 3P Project: A new approach to developing better treatments for TB 2015 [November 6, 2015]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.msfaccess.org\/spotlight-on\/3p-project-new-approach-developing-better-treatments-tb\" xlink:type=\"simple\">http:\/\/www.msfaccess.org\/spotlight-on\/3p-project-new-approach-developing-better-treatments-tb<\/ext-link>."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0155968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:52:37Z","timestamp":1540255957000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0155968"}},"subtitle":[],"editor":[{"given":"Dipankar","family":"Chatterji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,25]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0155968","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,25]]}}}